Cite Filings / LIMN / 0001104659-25-045628
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D

Beneficial Ownership Report

Liminatus Pharma, Inc. · Filed 2025-05-07 · Acc 0001104659-25-045628

Documents 1

  • SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2025-05-08 SCHEDULE 13D Beneficial Ownership Report
  • 2025-05-07 SCHEDULE 13D Beneficial Ownership Report
  • 2025-05-06 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure · Other events
  • 2025-05-01 3 Initial Statement of Ownership
  • 2025-04-30 3 Initial Statement of Ownership
  • 2025-04-30 3 Initial Statement of Ownership
  • 2025-04-30 3 Initial Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…